Administrative Core and Senior Leadership - Project Summary/Abstract The Cold Spring Harbor Laboratory Cancer Center is led by Bruce Stillman, Ph.D. (Gene Regulation and Cell Proliferation Program), David Tuveson, M.D., Ph.D. (Signal Transduction Program), Nicholas Tonks, Ph.D. (Signal Transduction Program), and Denise Roberts, Ph.D. (Administration). Stillman has been the Director of the CSHL Cancer Center since 1992, while concurrently holding the position of President of Cold Spring Harbor Laboratory. As Director, he is responsible for the overall direction, planning and fundraising to support cancer research and the Shared Resources. He is assisted in oversight of the Cancer Center by three Deputy Directors: Tuveson, Tonks, and Roberts. Tuveson, Deputy Director for Programs, is primarily responsible for oversight of the cancer research Programs and recruitment of new members to the Cancer Center. Tonks, Deputy Director for Shared Resources, supervises all the Shared Resource leaders, acts as a liaison between faculty, scientific staff and Shared Resource personnel, and provides leadership to maintain the highest quality scientific services. Roberts, Deputy Director for Administration, coordinates all administrative services on behalf of the Cancer Center, coordinates the Executive Committee of the Cancer Center and, with Tonks, oversees the Shared Resources. These four senior leaders are committed to maintaining and continually improving CSHL as a premier center for cancer research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA045508-31
Application #
9518761
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-08-01
Budget End
2019-07-31
Support Year
31
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Cold Spring Harbor Laboratory
Department
Type
DUNS #
065968786
City
Cold Spring Harbor
State
NY
Country
United States
Zip Code
11724
Krishnan, Navasona; Bonham, Christopher A; Rus, Ioana A et al. (2018) Harnessing insulin- and leptin-induced oxidation of PTP1B for therapeutic development. Nat Commun 9:283
Pommier, Arnaud; Anaparthy, Naishitha; Memos, Nicoletta et al. (2018) Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases. Science 360:
Krishnan, Navasona; Felice, Christy; Rivera, Keith et al. (2018) DPM-1001 decreased copper levels and ameliorated deficits in a mouse model of Wilson's disease. Genes Dev 32:944-952
Tiriac, Herve; Bucobo, Juan Carlos; Tzimas, Demetrios et al. (2018) Successful creation of pancreatic cancer organoids by means of EUS-guided fine-needle biopsy sampling for personalized cancer treatment. Gastrointest Endosc 87:1474-1480
Nattestad, Maria; Goodwin, Sara; Ng, Karen et al. (2018) Complex rearrangements and oncogene amplifications revealed by long-read DNA and RNA sequencing of a breast cancer cell line. Genome Res 28:1126-1135
Connell, Claire M; Raby, Sophie E M; Beh, Ian et al. (2018) Cancer Immunotherapy Trials Underutilize Immune Response Monitoring. Oncologist 23:116-117
Wong, Mandy S; Kinney, Justin B; Krainer, Adrian R (2018) Quantitative Activity Profile and Context Dependence of All Human 5' Splice Sites. Mol Cell 71:1012-1026.e3
Snider, Justin M; Snider, Ashley J; Obeid, Lina M et al. (2018) Probing de novo sphingolipid metabolism in mammalian cells utilizing mass spectrometry. J Lipid Res 59:1046-1057
Stacchiotti, Silvia; Mir, Olivier; Le Cesne, Axel et al. (2018) Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma. Oncologist 23:62-70
Banito, Ana; Li, Xiang; Laporte, Aimée N et al. (2018) The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma. Cancer Cell 33:527-541.e8

Showing the most recent 10 out of 380 publications